Schedule 13G ownership disclosure

Ovid therapeutics, Inc.

Security class unavailable · CUSIP: 690469101

Event date: 2021-04-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,500,000
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000342
Form type
SC 13G
Filer
Ovid Therapeutics Inc.
CIK
CIK 1636651
Filed
Apr 29, 2021
Reporting period
Apr 20, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub